Genzyme Corporation with financing story unusual compared to most biotechnology companies. This case is a series of financing used by Genzyme, along with the product - the market and corporate development strategy adopted by Henri Termeer, Genzyme's director general. Thus, the case allows students to assess the consistency of funding, "program", and not near unrelated proposal and examine them in the light of business strategy. "Hide
by Timothy A. Luehrman, Andrew D. Regan Source: Harvard Business School 18 pages. Publication Date: July 20, 1993. Prod. #: 294005-PDF-ENG
Related Case Solutions & Analyses:
Intel Corp.–1968-97
Thermo Electron Corp.
Birds Eye and the U.K. Frozen Food Industry (A)
BMW: The 7-Series Project (A)
MCI Vision (C)
Japan: A Concise Profile, 2014
All You Need is Love: Southwest Airlines and the Wright Amendment (A)
Hong Kong: The Pursuit of Freedom
Lundbeck Korea: Managing an International Growth engine.
Tiger Pride Enterprises
